Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ataseven

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|May 11, 2006
[Breast cancer]B Ataseven, W Eiermann
Geburtshilfe Und Frauenheilkunde|August 1, 2014
Subcutaneous Administration of Monoclonal Antibodies in OncologyC Jackisch, V Müller, C Maintz, et al.
Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|August 12, 2011
[Vaginal hysterectomy and bilateral adnexectomy for female to male transsexuals in an interdisciplinary concept]C Kaiser, I Stoll, B Ataseven, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Subcutaneous Trastuzumab for HER2-positive Breast Cancer - Evidence and Practical Experience in 7 German CentersC Jackisch, V Müller, P Dall, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2017
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patientsJ Gligorov, B Ataseven, M Verrill, et al.
Archives of Gynecology and Obstetrics|November 5, 2014
Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patientsB Ataseven, S Kümmel, W Weikel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancerJ Rom, G von Minckwitz, F Marmé, et al.
Geburtshilfe Und Frauenheilkunde|August 11, 2015
Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast CancerA Kümmel, S Kümmel, J Barinoff, et al.
British Journal of Cancer|October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancerS Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapyC Denkert, S Loibl, R Kronenwett, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|May 11, 2006
[Breast cancer]B Ataseven, W Eiermann
Geburtshilfe Und Frauenheilkunde|August 1, 2014
Subcutaneous Administration of Monoclonal Antibodies in OncologyC Jackisch, V Müller, C Maintz, et al.
Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|August 12, 2011
[Vaginal hysterectomy and bilateral adnexectomy for female to male transsexuals in an interdisciplinary concept]C Kaiser, I Stoll, B Ataseven, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Subcutaneous Trastuzumab for HER2-positive Breast Cancer - Evidence and Practical Experience in 7 German CentersC Jackisch, V Müller, P Dall, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2017
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patientsJ Gligorov, B Ataseven, M Verrill, et al.
Archives of Gynecology and Obstetrics|November 5, 2014
Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patientsB Ataseven, S Kümmel, W Weikel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancerJ Rom, G von Minckwitz, F Marmé, et al.
Geburtshilfe Und Frauenheilkunde|August 11, 2015
Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast CancerA Kümmel, S Kümmel, J Barinoff, et al.
British Journal of Cancer|October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancerS Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapyC Denkert, S Loibl, R Kronenwett, et al.
Pageof 2